DR. STEPHEN JACOB PANDOL, MD
Osteopathic Medicine at Wilshire Blvd, Los Angeles, CA
License number
California G033954
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California G033954
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address
11301 Wilshire Blvd, Los Angeles, CA 90073
Phone
(310) 478-3711
(310) 268-4578 (Fax)
(310) 268-4578 (Fax)
Personal information
See more information about STEPHEN JACOB PANDOL at radaris.comName
Address
Phone
1819 Outpost Dr, Los Angeles, CA 90068
223 S Medio Dr, Los Angeles, CA 90049
10524 Livewood Way, San Diego, CA 92131
91 Hadley Ln, Los Angeles, CA 90025
11693 San Vicente Blvd #153, Los Angeles, CA 90049
Professional information
Methods And Systems For Modulating Hormones And Related Methods, Agents And Compositions
US Patent:
2012005, Mar 8, 2012
Filed:
Jun 17, 2011
Appl. No.:
13/163638
Inventors:
Mark MENNA - LOS ANGELES CA, US
Stephen PANDOL - LOS ANGELES CA, US
Ravinder ABROL - Arcadia CA, US
Stephen PANDOL - LOS ANGELES CA, US
Ravinder ABROL - Arcadia CA, US
International Classification:
A61K 31/704, A61K 31/17, A61K 31/717, C08B 15/06, C12N 5/071, A61K 31/205, A61K 31/353, A61K 31/122, A61K 31/4745, A61K 31/10, A61K 31/12, A61K 31/366, A61K 31/352, G01N 33/566, A61P 3/04, A61P 3/10, A61P 3/00, A61P 1/16, A61P 9/00, A61K 31/513
US Classification:
514 33, 514274, 514585, 514 57, 536 31, 435375, 514555, 514456, 514691, 514280, 514279, 514713, 514679, 514453, 514690, 435 721
Abstract:
Provided herein are bitter taste receptor ligands, related agents, combinations, compositions, methods and systems for modulating release of a metabolic hormone in vitro or in vivo from cells of the GI tract of an individual.
Stephen Jacob Pandol, Los Angeles CA
Specialties:
Gastroenterologist
Address:
11301 Wilshire Blvd, Los Angeles, CA 90073
Education:
Saint Louis University, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Gastroenterology (Internal Medicine)
Dr. Stephen J Pandol - MD (Doctor of Medicine)
Hospitals:
8700 Beverly Blvd SUITE 7511, West Hollywood 90048
11301 Wilshire Blvd SUITE 258, Los Angeles 90073
Los Angeles Office
8700 Beverly Blvd, Los Angeles 90048
8700 Beverly Blvd SUITE 7511, West Hollywood 90048
11301 Wilshire Blvd SUITE 258, Los Angeles 90073
Los Angeles Office
8700 Beverly Blvd, Los Angeles 90048
11301 Wilshire Blvd SUITE 258, Los Angeles 90073
Los Angeles Office
8700 Beverly Blvd, Los Angeles 90048
8700 Beverly Blvd SUITE 7511, West Hollywood 90048
11301 Wilshire Blvd SUITE 258, Los Angeles 90073
Los Angeles Office
8700 Beverly Blvd, Los Angeles 90048
Education:
Medical Schools
Saint Louis University / School of Medicine
Graduated: 1975
Saint Louis University / School of Medicine
Graduated: 1975
Owner, Phyteau
Position:
Owner at Phyteau
Location:
Greater Los Angeles Area
Industry:
Food & Beverages
Work:
Phyteau
-
Owner
Compositions Comprising Plant-Derived Polyphenolic Compounds And Inhibitors Of Reactive Oxygen Species And Methods Of Using Thereof
US Patent:
2004025, Dec 23, 2004
Filed:
Apr 15, 2004
Appl. No.:
10/824597
Inventors:
Stephen Pandol - Los Angeles CA, US
Anna Gukovskaya - Agoura Hills CA, US
Moussa Yazbeck - Fort Smith AR, US
Guido Eibl - Los Angeles CA, US
Laszlo Boros - Los Angeles CA, US
Anna Gukovskaya - Agoura Hills CA, US
Moussa Yazbeck - Fort Smith AR, US
Guido Eibl - Los Angeles CA, US
Laszlo Boros - Los Angeles CA, US
International Classification:
A61K031/7048, A61K031/353, A61K031/198
US Classification:
514/027000, 514/456000, 514/561000, 514/733000, 514/743000
Abstract:
Disclosed are methods for treating, preventing, or inhibiting diseases and disorders associated with NF- B activation including proliferative diseases such as cancer and inflammatory diseases such as pancreatitis in a subject which comprises administering at least one polyphenolic compound and/or at least one inhibitor of reactive oxygen species to the subject. Also disclosed are pharmaceutical compositions comprising at least one polyphenolic compound and/or at least one inhibitor of reactive oxygen species. The polyphenolic compound may be derived or isolated from plants. In some embodiments, the polyphenolic compound is a flavonoid. In other embodiments, the polyphenolic compound is a non-flavonoid. Other methods and kits are also disclosed as well as pharmaceutical compositions.
Compositions Comprising Plant-Derived Polyphenolic Compounds And Inhibitors Of Reactive Oxygen Species And Methods Of Using Thereof
US Patent:
2004006, Apr 1, 2004
Filed:
Oct 1, 2002
Appl. No.:
10/260609
Inventors:
Stephen Pandol - Los Angeles CA, US
Anna Gukovskaya - Agoura Hills CA, US
Anna Gukovskaya - Agoura Hills CA, US
International Classification:
A61K031/7048, A61K031/7024, A61K031/198, A61K031/192
US Classification:
514/027000, 514/456000, 514/562000, 514/023000, 514/568000
Abstract:
Disclosed are methods for treating, preventing, or inhibiting cancer in a subject comprising administering at least one polyphenolic compound and at least one inhibitor of reactive oxygen species to the subject. The polyphenolic compound may be derived or isolated from plants. In some embodiments, the polyphenolic compound is a flavonoid. In other embodiments, the polyphenolic compound is a non-flavonoid. Other methods and kits are also disclosed as well as pharmaceutical compositions.
Methods For Treating Pancreatitis With Curcumin Compounds And Inhibitors Of Reactive Oxygen Species
US Patent:
7060733, Jun 13, 2006
Filed:
Aug 15, 2002
Appl. No.:
10/218518
Inventors:
Stephen J. Pandol - Los Angeles CA, US
Ilya Y. Gukovsky - Agoura Hills CA, US
Ilya Y. Gukovsky - Agoura Hills CA, US
Assignee:
The Regents of the University of California - Oakland CA
The United States of America as represented by the Department of Veterans' Affairs - Washington DC
The United States of America as represented by the Department of Veterans' Affairs - Washington DC
International Classification:
A61K 31/05
US Classification:
514731, 424756
Abstract:
Disclosed are methods of treating, preventing, modulating, attenuating, or inhibiting a disease or a disorder associated with inflammation related to NF-κB activation in a subject which comprises administering to the subject at least one curcumin compound. Also disclosed are combination therapies comprising the administration of at least one curcumin compound and at least one ROS inhibitor. Pharmaceutical compositions and kits are also disclosed.